By combining artificial intelligence with automated robotics and synthetic biology, researchers at the University of Illinois ...

Learn how first-line antiepileptic drugs, personalized care, and lifestyle changes work together to manage generalized ...

Macrocyclic peptides are designed to engage complex targets like biologics but pass through cell membranes like small ...

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...

Such detection speed is the result of combining ML and UV absorbance spectroscopy to detect microbial contamination in cell therapy products.

Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global ...

NFL super-agent Leigh Steinberg opens up about the brain trauma crisis in football and his mission to protect athletes ...

The biotech, which earlier this year laid off nearly all of its staff, also announced a PIPE that will hand it $175 million ...

Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis ...

QUEZON CITY (PIA) — Pasig City is set to offer free anti-pneumonia vaccines to 1,000 senior citizens and individuals with ...

Biologics revolutionize generalized myasthenia gravis care with fast-acting, patient-friendly therapies and a robust global pipeline redefining outcomes. The gMG treatment era is shifting rapidly-from ...